Skip to main content

February 2014 Vol 7, No 1, Special Issue ASH 2013 Payers' Perspectives in Oncology

Rituximab Infusions Costlier When Given in the Hospital

Hematologists Urged to Reduce Unnecessary Tests/Procedures, and Costs to Improve Quality of Care

Caroline Helwick

Peripheral T-Cell Lymphoma Associated with High Clinical Burden, Resource Utilization, and Costs

Significant Hospital Costs Tied to 30-Day Readmissions for Allogeneic Transplants

Physicians Must Consider the Financial Burden of Allogeneic Transplants

Clinical Practice Guidelines Should Include Patient’s Preferences

Adverse Events Reporting in Oncology Studies Suboptimal

Ibrutinib Approved for Chronic Lymphocytic Leukemia

Tafinlar Receives Breakthrough Therapy Designation for Lung Cancer

Hematologists Often Ignore Treatment and Monitoring Recommendations

Caroline Helwick

Page 3 of 4
Results 21 - 30 of 32